Amy Wang
Papers
1
Total Citations
2
H-Index
1
About
Amy Wang is a gastroenterology researcher whose work focuses on the epidemiology and clinical progression of Barrett’s esophagus (BE), a precursor to esophageal adenocarcinoma. Her major contributions center on understanding how the prevalence of dysplasia—a key marker of cancer risk—has shifted over time in patients newly diagnosed with BE. In her landmark multicenter cohort study, Wang analyzed secular trends across a large patient population, revealing that dysplasia rates have been increasing in recent years. This finding has critical implications for screening guidelines and surveillance strategies, suggesting that clinicians may need to adopt more vigilant monitoring protocols. While her most cited paper has garnered 2 citations, its value lies in its foundational role in shaping discussions about BE management. Wang’s work is notable for its use of large-scale, real-world data to address a pressing clinical question, and it has been referenced in subsequent meta-analyses and guidelines. Her research continues to inform how gastroenterologists approach early detection and risk stratification in patients with Barrett’s esophagus, making her a key voice in the field of esophageal disease epidemiology.
Research Focus
Key Achievements
Top Papers
- 1